Two Sigma Investments’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-36,000
| Closed | -$54K | – | 3323 |
|
|
2023
Q1 | $54K | Sell |
36,000
-84,677
| -70% | -$127K | ﹤0.01% | 2669 |
|
|
2022
Q4 | $121K | Sell |
120,677
-170,891
| -59% | -$171K | ﹤0.01% | 2425 |
|
|
2022
Q3 | $525K | Sell |
291,568
-38,089
| -12% | -$68.6K | ﹤0.01% | 1707 |
|
|
2022
Q2 | $956K | Sell |
329,657
-410,122
| -55% | -$1.19M | ﹤0.01% | 1513 |
|
|
2022
Q1 | $2.04M | Sell |
739,779
-24,625
| -3% | -$68K | 0.01% | 1313 |
|
|
2021
Q4 | $3.56M | Buy |
764,404
+442,545
| +137% | +$2.06M | 0.01% | 1053 |
|
|
2021
Q3 | $2.74M | Buy |
321,859
+63,413
| +25% | +$540K | 0.01% | 1193 |
|
|
2021
Q2 | $4.24M | Sell |
258,446
-39,879
| -13% | -$654K | 0.01% | 982 |
|
|
2021
Q1 | $6.59M | Buy |
298,325
+188,534
| +172% | +$4.16M | 0.02% | 729 |
|
|
2020
Q4 | $3.4M | Buy |
109,791
+99,473
| +964% | +$3.08M | 0.01% | 872 |
|
|
2020
Q3 | $210K | Buy |
+10,318
| New | +$210K | ﹤0.01% | 1669 |
|